You are viewing 9 posts matching the search bekelman

Justin Bekelman, ScienceDaily, Prostate Cancer Treatments

  • Wednesday, 13 March 2013

An article in the research news service ScienceDaily spotlights the findings of a new study led by LDI Senior Fellow Justin Bekelman of how financial incentives affect physicians' recommendations to cancer patients. "Our study found that ownership of radiation therapy equipment that offers high reimbursement rates has an impact on treatment…

Share |

Ezekiel Emanuel and Justin Bekelman, New York Times, Cancer Care Costs

  • Monday, 25 March 2013

In his latest New York Times' "Opinionator" column, LDI Senior Fellow Ezekiel Emanuel has asked 20 prominent members of the oncology community about how best to fix cancer care. The primary issue is the cost, which is the fastest-growing segment of the country's overall health care spending. One of the…

Share |

Justin Bekelman, Philadelphia Inquirer, Proton Therapy

  • Monday, 27 October 2014

In an article in the Philadelphia Inquirer Justin Bekelman warns that if insurers cease to pay for proton beam therapy for prostate cancer, it will not be possible to complete important clinical trials on that application of the technology.

Bekelman, MD, is an Assistant Professor of Radiation Oncology at Penn's Perelman…

Share |

Justin Bekelman, Multiple Media, Excessive Treatment Study

  • Thursday, 17 October 2013
LDI Senior Fellow Justin Bekelman's new study detailing the excessive use of high-cost radiation treatment in terminal cancer patients is getting extensive press pickup. Co-authored with LDI Senior Fellows Ezekiel Emanuel and Andrew Epstein, the study reports that more than 95% of advanced prostate cancer patients receive multiple radiation treatments for…
Share |

Justin Bekelman, MD featured in Radiology Today

  • Monday, 31 January 2011

Justin Bekelman, MD, Assistant Professor of Radiation Oncology, was featured in Radiology Today about new advances and treatments for prostate cancer.

(1/1/2011) Radiology Today Treating Prostate Cancer

Share |

Justin Bekelman, Washington Post, Research Integrity

  • Monday, 26 November 2012

The Washington Post cites a 2003 study by LDI Senior Fellow Justin Bekelman, MD in an article exploring how the pharmaceutical industry's growing influence over research increases the potential for bias. The Post reports "The odds of coming to a conclusion favorable to the industry are 3.6 times greater in research sponsored…

Share |

Justin Bekelman, HemOncToday, Proton Beam Therapy

  • Tuesday, 25 September 2012

An article in Healio HemOncToday about the high costs of proton beam therapy features the prostate cancer research study chaired by LDI Senior Fellow Justin Bekelman, MD, Assistant Professor of Radiation Oncology at Penn's Perelman School of Medicine. Penn, which opened a proton beam center in 2010, has partnered with Massachusetts…

Share |

Justin Bekelman, Wall Street Journal, Proton Beam Costs

  • Friday, 14 December 2012

LDI Senior Fellow Justin Bekelman, MD, is cited in the Wall Street Journal about a new study using Medicare records that found proton-beam therapy for prostate cancer provides no long-term benefit over traditional radiation treatments, despite higher costs. In a joint project with researchers at Massachusetts General Hospital, Bekelman, Assistant Professor…

Share |

Justin E. Bekelman, MD highlighted in Philadelphia Inquirer

  • Wednesday, 10 March 2010

Justin E. Bekelman, MD, assistant professor of Radiation Oncology, was highlighted in a Philadelphia Inquirer article for his new study on the type of treatment patients receive and how it significantly affects the type of specialist they see.

(3/10/10) Philadelphia Inquirer A reason to see primary care physician after prostate cancer diagnosis…

Share |